These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 31444850)

  • 21. Cyclopentitol as a scaffold for a natural product-like compound library for drug discovery.
    Padwal JD; Filippov DV; Narhe BD; Aertssen S; Beuving RJ; Benningshof JC; van der Marel GA; Overkleeft HS; van der Stelt M
    Bioorg Med Chem; 2015 Jun; 23(11):2650-5. PubMed ID: 25691210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synergism of virtual screening and medicinal chemistry: identification and optimization of allosteric antagonists of metabotropic glutamate receptor 1.
    Noeske T; Trifanova D; Kauss V; Renner S; Parsons CG; Schneider G; Weil T
    Bioorg Med Chem; 2009 Aug; 17(15):5708-15. PubMed ID: 19574055
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification and characterization of benzo[d]oxazol-2(3H)-one derivatives as the first potent and selective small-molecule inhibitors of chromodomain protein CDYL.
    Yang L; Liu Y; Fan M; Zhu G; Jin H; Liang J; Liu Z; Huang Z; Zhang L
    Eur J Med Chem; 2019 Nov; 182():111656. PubMed ID: 31494467
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potent achiral agonists of the growth hormone secretagogue (ghrelin) receptor. Part 2: Lead optimisation.
    Witherington J; Abberley L; Briggs MA; Collis K; Dean DK; Gaiba A; King NP; Kraus H; Shuker N; Steadman JG; Takle AK; Sanger G; Wadsworth G; Butler S; McKay F; Muir A; Winborn K; Heightman TD
    Bioorg Med Chem Lett; 2008 Mar; 18(6):2203-5. PubMed ID: 18316188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of Novel, Structurally Diverse, Small Molecule Modulators of GPR119.
    Nieto A; Fernández-Vega V; Spicer TP; Sturchler E; Adhikari P; Kennedy N; Mandat S; Chase P; Scampavia L; Bannister T; Hodder P; McDonald PH
    Assay Drug Dev Technol; 2018 Jul; 16(5):278-288. PubMed ID: 30019946
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A False-Positive Screening Hit in Fragment-Based Lead Discovery: Watch out for the Red Herring.
    Cramer J; Schiebel J; Wulsdorf T; Grohe K; Najbauer EE; Ehrmann FR; Radeva N; Zitzer N; Linne U; Linser R; Heine A; Klebe G
    Angew Chem Int Ed Engl; 2017 Feb; 56(7):1908-1913. PubMed ID: 28097765
    [TBL] [Abstract][Full Text] [Related]  

  • 27. From Protein Structure to Small-Molecules: Recent Advances and Applications to Fragment-Based Drug Discovery.
    Ferreira LG; Andricopulo AD
    Curr Top Med Chem; 2017; 17(20):2260-2270. PubMed ID: 28240184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Forging New Scaffolds from Old: Combining Scaffold Hopping and Hierarchical Virtual Screening for Identifying Novel Bcl-2 Inhibitors.
    Kanakaveti V; Rathinasamy S; Rayala SK; Gromiha M
    Curr Top Med Chem; 2019; 19(13):1162-1172. PubMed ID: 31210110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sequencing [4 + 1]-Cycloaddition and Aza-Michael Addition Reactions: A Diastereoselective Cascade for the Rapid Access of Pyrido[2',1':2,3]/Thiazolo[2',3':2,3]imidazo[1,5-
    Srinivasulu V; Khanfar M; Omar HA; ElAwady R; Sieburth SM; Sebastian A; Zaher DM; Al-Marzooq F; Hersi F; Al-Tel TH
    J Org Chem; 2019 Nov; 84(22):14476-14486. PubMed ID: 31633919
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of novel mPGES-1 inhibitors through screening of a chemical library.
    Park SJ; Han SG; Ahsan HM; Lee K; Lee JY; Shin JS; Lee KT; Kang NS; Yu YG
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7335-9. PubMed ID: 23147075
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A design strategy for drug-like polyheterocycles with privileged substructures for discovery of specific small-molecule modulators.
    Oh S; Park SB
    Chem Commun (Camb); 2011 Dec; 47(48):12754-61. PubMed ID: 21869959
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery of Mcl-1 inhibitors from integrated high throughput and virtual screening.
    Mady ASA; Liao C; Bajwa N; Kump KJ; Abulwerdi FA; Lev KL; Miao L; Grigsby SM; Perdih A; Stuckey JA; Du Y; Fu H; Nikolovska-Coleska Z
    Sci Rep; 2018 Jul; 8(1):10210. PubMed ID: 29976942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fragment-Based Phenotypic Lead Discovery: Cell-Based Assay to Target Leishmaniasis.
    Ayotte Y; Bilodeau F; Descoteaux A; LaPlante SR
    ChemMedChem; 2018 Jul; 13(14):1377-1386. PubMed ID: 29722149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a Focused Library of Triazole-Linked Privileged-Structure-Based Conjugates Leading to the Discovery of Novel Phenotypic Hits against Protozoan Parasitic Infections.
    Uliassi E; Piazzi L; Belluti F; Mazzanti A; Kaiser M; Brun R; Moraes CB; Freitas-Junior LH; Gul S; Kuzikov M; Ellinger B; Borsari C; Costi MP; Bolognesi ML
    ChemMedChem; 2018 Apr; 13(7):678-683. PubMed ID: 29451361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ghrelin Receptor Ligands Reaching Clinical Trials: From Peptides to Peptidomimetics; from Agonists to Antagonists.
    Vodnik M; Štrukelj B; Lunder M
    Horm Metab Res; 2016 Jan; 48(1):1-15. PubMed ID: 26551992
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural diversity and potency range distribution of scaffolds from compounds active against current pharmaceutical targets.
    Kayastha S; Dimova D; Stumpfe D; Bajorath J
    Future Med Chem; 2015; 7(2):111-22. PubMed ID: 25686001
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of new erbB4 inhibitors: Repositioning an orphan chemical library by inverse virtual screening.
    Giordano A; Forte G; Massimo L; Riccio R; Bifulco G; Di Micco S
    Eur J Med Chem; 2018 May; 152():253-263. PubMed ID: 29730188
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biphenyl Acid Derivatives as APJ Receptor Agonists.
    Su S; Clarke A; Han Y; Chao HJ; Bostwick J; Schumacher W; Wang T; Yan M; Hsu MY; Simmons E; Luk C; Xu C; Dabros M; Galella M; Onorato J; Gordon D; Wexler R; Gargalovic PS; Lawrence RM
    J Med Chem; 2019 Nov; 62(22):10456-10465. PubMed ID: 31724863
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery of allosteric modulators for GABAA receptors by ligand-directed chemistry.
    Yamaura K; Kiyonaka S; Numata T; Inoue R; Hamachi I
    Nat Chem Biol; 2016 Oct; 12(10):822-30. PubMed ID: 27526031
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hit triage using efficiency indices after screening of compound libraries in drug discovery.
    Reitz AB; Smith GR; Tounge BA; Reynolds CH
    Curr Top Med Chem; 2009; 9(18):1718-24. PubMed ID: 19929837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.